CME‎ > ‎

Novel Anticoagulants

posted Mar 13, 2014, 12:39 PM by Yasser Mohamed Abdelhamid   [ updated Mar 18, 2014, 12:14 PM ]

Four 'New' Oral Anticoagulant Stroke-Protection Benefits in AF Cut Across Subgroups in Meta-Analysis.

dabigatran (Pradaxa),  rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Lixana).More effective and more safe than warfarin


Comments